Back to search

Article

ANCA-associated vasculitis following secukinumab treatment for psoriasis: Expanding the Spectrum of IL-17A Inhibitor-Related Autoimmunity— A Case Report

2026-06-22

Abstract excerpt

<title>Abstract</title> <p>Background Secukinumab, a fully human monoclonal antibody targeting interleukin-17A, is widely used for the treatment of psoriasis and psoriatic arthritis. Although generally well-tolerated, rare immune-mediated adverse events have been reported with increasing real-world use. We report the first case of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) developing...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
52b1ddc8-6611-5cce-978a-fa9756c15ffb
DOI
10.21203/rs.3.rs-9887892/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ANCA-associated vasculitis following secukinumab treatment for psoriasis: Expanding the Spectrum of IL-17A Inhibitor-Related Autoimmunity— A Case ReportDOI 10.21203/rs.3.rs-9887892/v1
Select a neighboring publication to make it the new centre.